XNAS: OTLK
Outlook Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an oph...
Read More
0.23
0.00
(0.00%)
3.0M
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Outlook Therapeutics Inc is on 15 May 2026 for the purpose of Outlook Therapeutics Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Outlook Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..